Navigation Links
Jackson’s Stem Cell Research Donation Does Not Please New Zealander

New Zealand filmmaker Peter Jackson and Fran Walsh’s donation of $500,000 to the University of California for stem cell research has not gone down well in their home// country. Citing that stem cell research could find cure for incurable diseases, Jackson said that they hoped the donation could be put to good use.

"We have lost close friends and relatives to cancer and Parkinson's disease, and the level of personal suffering inflicted on patients and their families by these diseases is horrific," Jackson said. "(Stem cell therapy) has the capacity to exponentially improve the quality of life for those who currently suffer from spinal cord injury, diabetes, Parkinson's disease, and many other debilitating medical conditions."

The donation will be called the Bill and Joan Jackson Scholars Fund after Jackson's parents. However professor Mike Berridge, who studies cancer stem cells at Wellington's Malaghan Institute said it was sad that they did not decide to donate locally.

"I'm stunned that New Zealand dollars are being given overseas but I'm not surprised because there's not an awareness of what's going on in New Zealand in many areas of research," he said. He said work at Malaghan and Auckland University was focused on stem cells and their ability to combat cancer.

Even Science Minister Steve Maharey conceded that the donation showed more needed to be done to spread awareness of the exemplary work being done in NZ.


'"/>




Page: 1

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Jackson Stem Cell Research Donation Does Not Please New Zealander

(Date:7/1/2015)... ... 01, 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, ... Rhinoplasty Symposium . Set for March 6th - 8th, the 2016 meeting will be ... basic training and fundamentals of nasal surgery through the most modern advancements and updates ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... leaders Lora Posey (Manager, National Sales Training and Development) and Chuck Corso (Associate ... (LTEN) Conference in Phoenix, AZ. LTEN brings together learning and development professionals from ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the ... 5K on August 15-16th (MSG Keys’ birthday) in memory of her late husband and ... soldier and recipient of the Bronze Star Medal, died during a Special Forces training ...
(Date:7/1/2015)... Florida (PRWEB) , ... July 01, 2015 , ... ... for society,” said lead author Lisa Stolzenberg, a Professor in FIU’s School of ... juveniles aged 12 to 17 years who participated in the National Survey on ...
(Date:7/1/2015)... NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in which ... National Scoliosis Foundation, it affects 2 to 3 percent of the population, or an estimated ... most often develops in children between the ages of 10 and 15. Most types of ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4
... Symbol: DND, MISSISSAUGA, ON, Nov. 7 /PRNewswire-FirstCall/ - Cipher ... for,the three and nine months ended September 30, 2007. ... into a licensing and distribution agreement with ProEthic ... exclusive right to market, sell ...
... Globe, ATLANTA, Nov. 7 A midpoint assessment ... incidence by,one-fourth by 2015 finds overall cancer incidence rates ... 1992. Despite those gains, the authors of,the report say ... the challenge,period was only about half the size necessary ...
... Providence Service,Corporation (Nasdaq: PRSC ) today announced the ... Senior Subordinated Notes due in,2014. RBC Capital Markets ... The private placement was priced off today,s closing price ... and are convertible into,Providence common shares at a conversion ...
... revenues of $12.1 million - up 29% over third quarter 2006 -- Net ... ... revenues of $3.5 million - up 28% ... $1.8 million - up 65% over third ...
... Net income increases 109% and net premiums written increase 21% over ... comparable year-earlier quarterly results., FARMINGTON, Conn., ... (NYSE: DR ) today,announced its financial results for the third ... for the third quarter are $69.3 million. Third ...
... on Growth Businesses, LEHIGH VALLEY, Pa., Nov. 6 ... AG are in advanced discussions over Wacker,s,purchase of Air ... (WPS) and Air Products Polymers (APP), including APP,s,vinyl acetate-ethylene ... 35 percent. As for WPS, Wacker owns 80 percent ...
Cached Medicine News:Health News:Cipher reports third quarter fiscal 2007 results 2Health News:Cipher reports third quarter fiscal 2007 results 3Health News:Cipher reports third quarter fiscal 2007 results 4Health News:Cipher reports third quarter fiscal 2007 results 5Health News:Cipher reports third quarter fiscal 2007 results 6Health News:Cipher reports third quarter fiscal 2007 results 7Health News:Cipher reports third quarter fiscal 2007 results 8Health News:Cipher reports third quarter fiscal 2007 results 9Health News:Cipher reports third quarter fiscal 2007 results 10Health News:Cipher reports third quarter fiscal 2007 results 11Health News:Cipher reports third quarter fiscal 2007 results 12Health News:Cipher reports third quarter fiscal 2007 results 13Health News:Cipher reports third quarter fiscal 2007 results 14Health News:Cipher reports third quarter fiscal 2007 results 15Health News:Cipher reports third quarter fiscal 2007 results 16Health News:Cipher reports third quarter fiscal 2007 results 17Health News:Cipher reports third quarter fiscal 2007 results 18Health News:Cipher reports third quarter fiscal 2007 results 19Health News:Cipher reports third quarter fiscal 2007 results 20Health News:Cancer Incidence in the United States: A Progress Report 2Health News:Cancer Incidence in the United States: A Progress Report 3Health News:Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes 2Health News:AtriCure Reports Third Quarter 2007 Financial Results 2Health News:AtriCure Reports Third Quarter 2007 Financial Results 3Health News:AtriCure Reports Third Quarter 2007 Financial Results 4Health News:AtriCure Reports Third Quarter 2007 Financial Results 5Health News:AtriCure Reports Third Quarter 2007 Financial Results 6Health News:AtriCure Reports Third Quarter 2007 Financial Results 7Health News:AtriCure Reports Third Quarter 2007 Financial Results 8Health News:AtriCure Reports Third Quarter 2007 Financial Results 9Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 6
(Date:7/1/2015)... Ill. , July 1, 2015 ... nationwide group of state and regional professional rheumatology ... survey of rheumatologists that explored perceptions of biosimilars ... on patients. Biosimilars are medicines ... biologic medicines. They are notably different from generic ...
(Date:7/1/2015)... 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... corporate presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief ... a business and financial update on Wednesday, July 8, 2015 ... A live audio webcast of the presentation may be ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: